BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 7317114)

  • 1. Natural cell-mediated cytotoxicity in Sjögren's syndrome and rheumatoid arthritis.
    Goto M; Tanimoto K; Chihara T; Horiuchi Y
    Arthritis Rheum; 1981 Nov; 24(11):1377-82. PubMed ID: 7317114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
    Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
    J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
    Theander E; Jacobsson LT
    Rheum Dis Clin North Am; 2008 Nov; 34(4):935-47, viii-ix. PubMed ID: 18984413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjogren's syndrome and pseudolymphoma.
    Deutsch HJ
    Ann Otol Rhinol Laryngol; 1967 Dec; 76(5):1074-84. PubMed ID: 6074240
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of serum anti-salivary duct antibody and its clinical significance].
    Zhang H; Shi GY; Cai XH
    Zhonghua Nei Ke Za Zhi; 1990 Nov; 29(11):666-8, 702. PubMed ID: 2086008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid gland disorders in primary Sjögren's syndrome.
    Punzi L; Ostuni PA; Betterle C; De Sandre P; Botsios C; Gambari PF
    Rev Rhum Engl Ed; 1996 Dec; 63(11):809-14. PubMed ID: 9010968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiperinuclear factor in Sjögren's syndrome in the presence or absence of rheumatoid arthritis.
    Youinou P; Pennec Y; Le Goff P; Ferec C; Morrow WJ; Le Menn G
    Clin Exp Rheumatol; 1984; 2(1):5-9. PubMed ID: 6335861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver disease in Sjögren's syndrome and rheumatoid arthritis.
    Whaley K; Goudie RB; Williamson J; Nuki G; Dick WC; Buchanan WW
    Lancet; 1970 Apr; 1(7652):861-3. PubMed ID: 4191507
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of myasthenia associated with rheumatoid arthritis and Sjögren's syndrome].
    Yoshino S; Morishige T; Fujimori J; Kawashima K
    Ryumachi; 1982 Aug; 22(4):315-20. PubMed ID: 7179027
    [No Abstract]   [Full Text] [Related]  

  • 12. Sjögren's syndrome associated with HLA-Dw3.
    Chused TM; Kassan SS; Opelz G; Moutsopoulos HM; Terasaki PI
    N Engl J Med; 1977 Apr; 296(16):895-7. PubMed ID: 846509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of membranous glomerulonephritis in a patient with rheumatoid arthritis and Sjögren's syndrome.
    Schwartzberg M; Burnstein SL; Calabro JJ; Jacobs JB
    J Rheumatol; 1979; 6(1):65-70. PubMed ID: 439113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody defined T cell subsets in primary and secondary Sjögren's syndrome.
    Fossaluzza V; Rossi P; Tosato F; Pirrone S; Tonutti E; Sala PG
    Boll Ist Sieroter Milan; 1986; 65(5):440-2. PubMed ID: 3493793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
    Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
    Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Natural cytotoxicity in Sjögren's syndrome].
    Aleksandrova EN; Nasonov EL; Vasil'ev VI; Bykhovskaia SIu; Zimin IuI
    Ter Arkh; 1984; 56(7):103-6. PubMed ID: 6484820
    [No Abstract]   [Full Text] [Related]  

  • 17. Stratifying primary Sjögren's syndrome: killers in the balance?
    Bowman SJ; Fisher BA
    Arthritis Res Ther; 2015 Dec; 17():351. PubMed ID: 26639390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis.
    Mattey DL; González-Gay MA; Hajeer AH; Dababneh A; Thomson W; García-Porrúa C; Ollier WE
    J Rheumatol; 2000 Nov; 27(11):2611-6. PubMed ID: 11093441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-Bw44 and HLA-DRw4 in male Sjögren's syndrome patients with associated rheumatoid arthritis.
    Powell TR; Michalski JP; McCombs CC; Danilovs JA; Terasaki PI; Park MS; Flood T; Boone WB
    Clin Immunol Immunopathol; 1980 Nov; 17(3):463-8. PubMed ID: 6933029
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.